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Abstract: The interactions of two fragments of the human antimicrobial LL-37 (LL-
32 and LL-20) with lipidmonolayers at the soft liquid/air interface have been char-
acterized. Tomodel the interactionwithmammalian cellmembranes, lipidmono-
layers composed of the zwitterionic DPPC andDOPCwere used. To investigate the
interaction with bacterial cell membranes, lipid monolayers of anionic DPPG and
POPG were used. DPPC and DPPG exhibit a first-order phase transition from the
disordered liquid to the ordered condensed state, whereas POPGandDOPCmono-
layers are in the fluid disordered state at all surface pressures studied. Therefore,
the influence of the monolayer phase state on peptide-lipid interactions can be
studied. To obtain insight into the peptide structure and their influence on phos-
pholipidmembranes, film balancemeasurements were coupled with surface sen-
sitive InfraredReflection-Absorption Spectroscopy (IRRAS). The results were com-
pared to CD measurements in bulk.
LL-32 is more surface active and can better intercalate into lipid monolayers than
LL-20. Even though LL-32 has no cell-selectivity, our results show how the pep-
tide interacts differently with zwitterionic compared to anionic membrane mod-
els. The interaction with DPPCmonolayers is based on simple intercalation of the
peptides between the lipid molecules. However, the peptides bind in a two-step
process to DPPGmonolayers, which results in afluidization of the lipid film. This
can be related to amembrane thinning.
Keywords:Antimicrobial Peptides, LipidMonolayers, Fluid Interfaces, FTIR Spec-
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1 Introduction
Antimicrobial peptides (AMPs), also termed host defense peptides, are part of
the immune defense system and can be found in every organism [1–3]. Beyond
their antibacterial, antifungal and antiviral activities, they are also involved in im-
munomodulatory activities and inflammatory processes [4, 5] and some are even
active against cancer cells [6–8]. AMPs are highly selective and do not attack host
cells and thus can be used as lead structures for the development of new drugs
complementing standard antibiotic therapies [9, 10]. AMPs kill bacteria within 15
to 90min [11] and their target is always themembrane. Besides that, antimicrobial
peptides can also be involved in biochemical processes like the inactivation of nu-
cleic acids and cytoplasmic proteins [11]. More than thousand AMPs are identified
and published in databases [12, 13], but their mode of action is still not completely
understood [11, 14, 15].
Several modes of action are discussed for AMPs, including a ‘carpet model’,
or the formation of ‘barrel-stave’ or ‘toroidal pores’, where the peptides pene-
trate the lipid bilayer [6, 12, 16, 17]. For an interaction with the membrane via a
‘carpet mechanism’, the peptides cover the membrane surface, interact primarily
with the lipid head groups, and are oriented parallel to the surface. The forma-
tion of a special secondary structure and penetration of the peptides into the hy-
drophobic core of the bilayer are not mandatory. The membrane is disrupted in
a detergent-like way. Polymyxin B is thought to act via that mechanism [18]. The
peptides can induce lesions by arranging parallel to the membrane, even without
forming pores. But the exact mechanism is still unclear.
One class of amphipathic, cationic, 𝛼-helical AMPs is the class of catheli-
cidins. In humans, only one AMP from this class is found, namely LL-37 [19, 20].
LL-37 is released from its precursor hCAP18 by proteases [21] and stored in the in-
tracellular granules of neutrophilic granulocytes [22]. Initially identified solely as
anantimicrobial protein, hCAP18/LL-37 ismultifunctionalwithdiverse and signif-
icant effects on eukaryotic cells [23]. It exhibits hemolytic activity [24, 25] and is cy-
totoxic against Gram-positive andGram-negativebacteria [20, 25] aswell as tumor
cells [26]. LL-37 is also active against viruses [27]. Furthermore, LL-37 can bind and
neutralize lipopolysaccharides (LPS) from the cell membrane of Gram-negative
bacteria [28, 29]. LL-37 binds as oligomers to zwitterionicmembranes [30], but dis-
sociates intomonomerswhen in contactwith negatively chargedmembranes [24].
In aprevious study, the surface activity and structures of two fragments (LL-
20 and LL-32) of LL-37 at the soft liquid/air interface have been characterized [31].
It was shown that the peptides differ drastically in their surface activity (equi-
librium adsorption pressure). As concluded from CD spectra, both peptides are
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unstructured in bulk but exhibit different secondary structures when adsorbed to
the air/buffer interface [31, 32]. While LL-32 transforms into an 𝛼-helix lying flat
at the buffer surface, with a helix diameter of 17 Å, LL-20 adopts a partly unstruc-
tured conformation. The ability of LL-32 to form aperfect 𝛼-helical structure at the
interface is in good agreement with its higher antimicrobial activity.
The experiments with lipid monolayers will examine the influence of lipid
charges and packing parameters on the surface activity of the peptide fragments.
Moreover, because of the presence of LL-37 in the lung, on the skin, in sweat,
andwoundfluids [33], the air/buffer interface receives a biological relevance. Two
fragments of LL-37, named LL-20 and LL-32, have been used. Both fragments lack
the unstructured C-terminal part of the peptide. The antibacterial activity of LL-32
is increased compared to LL-37 [20, 34]. On the contrary, LL-20 exhibits a reduced
antibacterial activity [35] compared to LL-37, probably because it lacks the as-
sumed antimicrobial active core LL-37 [18, 29]. LL-32 carries a net charge of+6 (like
LL-37), while LL-20 carries a smaller net charge of +4.
Planar lipid films provide a useful model system to study peptide-lipid inter-
actions, if one combines the Langmuir trough technique with surface sensitive
methods [36–42].
Zwitterionic phosphatidylcholines (PCs) are often used to model the eukary-
otic cellmembrane,whereasnegatively chargedphosphatidylglycerols (PGs)have
been used to mimic the cytoplasmic bacterial membrane [43, 44]. Length and de-
gree of saturation of the lipid hydrocarbon tails play a significant role in mem-
brane viscoelastic properties for bothmammalianand bacterial cells. The present
study is focused on the ability of the peptides to penetrate into different lipid lay-
ers, which can give deeper insight into the processes of destroying the bacterial
but not the human cell membrane.
The aim of this work is to find decisive differences between the membrane
interactions of these fragments.
2 Experimental
2.1 Materials
Peptides: The two fragments of LL-37, namely LL-20 and LL-32, were synthesized
with C-terminal amidation by solid-phase peptide synthesis technique with an
automatic peptide synthesizer (model 433 A; Applied Biosystems) on Rink amide
resin according to the fastmoc synthesis protocol of the manufacturer, including
the removal of the N-terminal Fmoc-group [31]. The peptide was cleaved from the
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resin and deprotected and with 90% trifluoroacetic acid (TFA), 5% anisole, 2%
thioanisole, 3% dithiothreitol for 3 h at room temperature. After cleavage the sus-
pension was filtered and the soluble peptides were precipitated with ice-cold di-
ethylether followed by centrifugation and extensive washing with ether. Peptides
were purified by RP-HPLC using a Jupiter 4𝜇 Proteo column (Phenomenex). Elu-
tion was done by using a gradient of 0%–70% acetonitrile in 0.1% (TFA) to pu-
rities above 95%. The purity was determined by analytical reversed-phase HPLC
(UV 214 nm) and matrix-assisted laser-desorption-time-of-flight mass spectrom-
etry (MALDI-TOF MS, Bruker). The masses are 3922 Da for LL-32 and 2465 Da for
LL-20. The aqueous solutions were prepared using ultrapure water (specific resis-
tance of 18.2M𝛺 cm) produced by aMillipore reverse osmosis unit. Film balance
measurements were performed on buffer with 5mM HEPES (Roth, Germany),
pH 7.4, 100mM NaCl (Merck, Germany, heated to 600 ∘C before use to remove
organic surface active impurities). All experiments were carried out at 20 ∘C.
Lipids: Zwitterionic 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC),
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), and anionic 1,2-dipalmitoyl-
sn-glycero-3-phospho-(1’-rac-glycerol) (DPPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-(1’-rac-glycerol) (POPG) were purchased from Avanti Polar Lipids (USA)
and stored at −20 ∘C. For experiments, the lipids were dissolved in chloroform to
a concentration of 1mM and kept at 4 ∘C.
2.2 Langmuir film balance
The adsorption experiments and other studies at the air-water interface were
performed in PTFE Langmuir troughs (Riegler &Kirstein, Potsdam, Germany),
equipped with barriers for controlling the area per molecule, and aWilhelmy mi-
crobalance with filter paper plate for measuring the surface tension of the mono-
layer. The temperature of the subphase was kept constant at (20 ± 0.5) ∘C by
a thermostat.
The interaction between peptides and phospholipids was studied by spread-
ing the lipid monolayers on the subphase containing the peptide. The initial sur-
face pressure of the 0.2 μM peptide solution was 0mN/m. The amount of spread
lipids was calculated from their individual 𝜋-A isotherms to give 𝜋 = 0mN/m.
The collection of the surface pressure data was started before spreading.
The maximum insertion pressure (MIP) of LL-32 and LL-20 into lipid mono-
layers was studied by injection of the corresponding peptide solution underneath
a pre-compressed lipid monolayer at a defined surface pressure 𝜋i. In contrast to
the first experiments, the lipid was spread on top of the pure buffer solution, and
left for at least 15min for the solvent evaporation. The formed monolayer was
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compressed to a certain surface pressure, and the barriers were stopped. The to-
tal area of the surface was kept constant during the adsorption process. Injec-
tion of a concentrated peptide stock solution is inexpedient without stirring the
subphase because of the formation of a strong concentration gradient. The final
peptide concentration after injection into the subphase and careful manual stir-
ringwas again 0.2 μM as in the above described experiment. Collection of surface
pressure data was started before injection.
2.3 Infrared Reflection Absorption Spectroscopy (IRRAS)
IRRA spectra were recorded with the Vertex 70 FT-IR spectrometer (Bruker, Ger-
many) coupled to a Langmuir film balance (Riegler &Kirstein, Germany) with
a total area of 182 cm2 and two movable barriers. The surface pressure was
measured by using filter paper as aWilhelmy plate after filling the trough with
a 0.2 μM peptide solution. Angles of incidence were varied between 30∘ and 70∘,
the polarization of the beam was modulated to perpendicular (s) and parallel
(p) polarized light. The reflected IR beam was detected at the same angles with
a liquid nitrogen cooled MCT detector. Due to the shuttle technique, a pure sub-
phase spectrum R
0
is recorded before the sample spectrum R is measured and the
reflectance-absorbance is plotted as − lg(R/R
0
). Therefore, the strong absorption
bands fromwater can bemostly eliminated. Details of the technique can be found
in [45–50]. The spectra were atmospheric compensated in OPUS 6.0 and shifted to
zero at 1900 cm−1. The dichroic ratio was calculated by dividing the intensity of
the Amide I band using p-polarized light by that using s-polarized light.
3 Results
3.1 Interactions of LL-32 and LL-20 with un-compressed
monolayers
The corresponding lipid solution is spread on a homogeneous peptide subphase.
The amount of lipid used is such that the initial surface pressure is zero (close to
the lift-off point of the isotherms determined on the corresponding buffer). The
increase in surface pressure with time reflects the peptide adsorption to the in-
terface. Differences in the equilibrium surface pressure give information about
the preference of the peptide for the different model membranes [51]. DPPC and
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Figure 1: Adsorption kinetics of LL-32 (solid) and LL-20 (dotted-dashed) to DPPG (left) DPPC
(right) monolayers. 5 mM HEPES, 100mMNaCl, pH 7.4, 20 ∘C, 0.2 μM peptide in solution.
DPPG (both lipids exhibit a first-order LE/LC transition on the buffer used) have
been used to mimic mammalian or bacteria cell membranes, respectively.
Spreading of the DPPG solution on the peptide-containing subphase leads to
a strong increase in the surface pressure (Figure 1 left).
A small plateau in the 𝜋 = 𝑓(𝑡) adsorption kinetics can be seen for both
peptides connected with the LE/LC phase transition of DPPG around 10mN/m.
A second plateau at 25mN/m must be connected with reorientation processes
within the mixed surface layer. The equilibrium pressure for both peptides is
increased in the presence of DPPG (35mN/m compared to 25mN/m for LL-32
alone; 22mN/m compared to 6mN/m for LL-20 alone). The equilibrium surface
pressure is reachedmuch faster for the less active LL-20, indicating additional in-
teractions of LL-32 with DPPG.
The peptide adsorption to DPPC (Figure 1 right) leads to a surface pressure
increase of 8.5mN/m in the presence of LL-20, and to 25mN/m in the presence
of LL-32. These values are comparable with the peptide equilibrium pressures at
the bare air/buffer interface, indicating the absence of specific interactions of the
peptides with DPPC. The adsorption kinetics of LL-32 shows again a small plateau
connected with the first-order LE/LC phase transition in the DPPC monolayer. In
the case of LL-20, the peptide adsorption leads only to a surface pressure close to
the transition pressure so that the plateau cannot be observed.
IRRAS experiments have been used to identify the phase of the lipid mono-
layers. Both peptides lead to a fluidization of the DPPGmonolayer. After reaching
the adsorption equilibrium, the position and the dichroic ratio of the asymmet-
ricCH
2
vibrational bands agree well with those of a DPPGmonolayer in a liquid-
expanded phase (Figure 2). This is surprising, since the equilibrium pressure is
much higher than the phase transition pressure of a DPPGmonolayer on the bare
buffer (∼10mN/m).
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Figure 2: CH
2
stretching vibrations of mixed DPPG/LL-32 films at 𝜋eq = 35mN/m (solid line,
shifted upwards for clarity) and LL-20 at 𝜋eq = 22mN/m (dotted) and 𝜋 = 30mN/m
(dotted-dashed). 5 mM HEPES, 100mMNaCl, pH 7.4, 20 ∘C, 0.2 μM peptide in solution.
Figure 3:Maxima of the asymmetric CH
2
vibrational band (left) and maxima of the amide I band
(right) as a function of the surface pressure 𝜋 for DPPG (◼) as well as DPPG/LL-32 (∙) and
DPPG/LL-20 (∘). 5 mM HEPES, 100mMNaCl, pH 7.4, 20 ∘C, 0.2 μM peptide in solution. The lines
are only to guide the eye.
During the adsorption process (Figure 1), the adsorption/penetration of LL-32
induces first the LE/LC transition of DPPG (small plateau in the 𝜋 = 𝑓(𝑡) curve
and the shift of 𝜈as(CH2) to lower wavenumbers (2920 cm
−1 at 10mN/m)) which
is followed by afluidization of the DPPG layer with 𝜈as(CH2) at 2923 cm
−1 (ex-
panded state) for surface pressures >20mN/m (Figure 3 left). LL-20, which ad-
sorbs much faster, shifts first the methylene vibration to 2921 cm−1 (condensed
state) which then increases again to 2923 cm−1 (expanded state) for surface
pressures >15mN/m. This indicates clearly that the peptide adsorption leads
first to an alkyl chain ordering due to increased packing densities and then to
a fluidization due to specific peptide-lipid interactions. Therefore, the second
‘plateau’ in the adsorption kinetics above 25mN/mmight also be connectedwith
the reentrant transition into the LE phase.
The DPPG/LL-20 film (𝜋eq ∼ 22mN/m) could be further compressed to
30mN/m. The asymmetric CH
2
band position shifts back to 2920 cm−1. This
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shows that a squeezing-out of the peptide occurs above 𝜋eq allowing the re-
condensation of the DPPG layer.
During the adsorption process, a shift in the amide I band position to lower
frequencies (Figure 3 right) has been observed. A red-shift in the amide I band po-
sition canbe attributed to the formation of hydrogen bonds [44, 52, 53] or a change
in the helix flexibility [54]. Also, a change in the backbone hydration influences
slightly the band position. This can be due to an aggregation of the peptide [55–
57] or a deeper incorporation into the hydrophobic environment. Both events are
connected with the partial dehydration of the C=O groups. As shown in [31], LL-
20 adopts a less distinct 𝛼-helix with more contact to water. The stronger shift for
LL-32/DPPG mixtures could be therefore explained by adeeper insertion of LL-32
compared to LL-20 or simply by the formation of amore perfect 𝛼-helix in contact
with DPPG. In equilibrium, the amide I band can be fitted with two Lorentzian
curveswithmaximaat1657.8 cm−1 and 1679 cm−1 for LL-32 and 1658.1 cm−1 and
1668.2 cm
−1 for LL-20. The high energy band can be attributed to the vibration of
non-hydrogen bonded C=O groups [58].
To compare the orientation of the peptides, the dichroic ratio (intensity of the
p-polarized light divided by the intensity of the s-polarized light) of the amide I
band has been analyzed [50, 59]. It is independent of the concentration or length
of the peptides and allows comparisons regarding the orientation in both, in-
plane and out-of-plane directions. The dichroic ratio of the amide I band is compa-
rable for both peptides, indicating that both peptides adopt the same orientation
when interactingwithDPPG. But the values are slightly below the values expected
for a complete 𝛼-helix lying flat at the air/water interface [31].
The interaction of the peptides with zwitterionic DPPC is clearly different
from that with the anionic DPPG (compare the adsorption kinetics). LL-32 adsorbs
at the interface and compresses the DPPC layer into the condensed state. The
LE/LC transition can be already seen in the adsorption kinetics. The methylene
stretching vibrations (Figure 4 left) shift to wavenumbers (𝜈as ∼ 2919 cm
−1 and
𝜈s ∼ 2850 cm
−1) indicative for the all-trans conformation of the alkyl chains. The
band intensity increases due to increased packingdensity and to the change in the
orientation of the transition dipole moment by undergoing the fluid-condensed
transition [53]. The dichroic ratio of DPPC/LL-32 agrees well with the value of
a pure DPPC film at the same surface pressure indicating a similar monolayer
structure. The adsorption of LL-20 leads to a lateral pressure of only 7.5mN/m, at
whichDPPC is still in the LE phase indicatedby the highwavenumbers of theCH
2
stretchingbands (𝜈as ∼ 2923 cm
−1 and𝜈s ∼ 2854 cm
−1). Thepresenceof bothpep-
tides at the interface can be detected by the appearance of amide bands (Figure 4
right).
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Figure 4: CH
2
band region (left) and amide I band region (right) of DPPC/peptide mixtures.
DPPC/LL-32 at 𝜋eq = 25mN/m (solid) and 𝜋 = 30mN/m (dotted), DPPC/LL-20 at
𝜋eq = 7.5 mN/m (dotted-dashed) and 𝜋 = 30mN/m (dashed). 5 mM HEPES, 100 mMNaCl,
pH 7.4, 20 ∘C, 0.2 μM peptide in solution.
Compression of the mixed peptide/DPPC films to 30mN/m leads to a shift
to lower wavenumbers of the CH
2
stretching vibrations as observed for the pure
condensed DPPC film at the bare air/buffer interface. The less effective LL-20 is
completely squeezed-out from the DPPC film (absence of amide bands, see Fig-
ure 4 right). This is not the case for LL-32. The presence of amide bands in the
spectra indicates that LL-32 is still located at the interface and influences the lipid
monolayer structure. However, the amide band intensity is decreased and the es-
ter bandofDPPC is increased indicating that at least apart of LL-32 is squeezed-out
and replaced by DPPC.
3.2 Interactions of LL-32 and LL-20 with pre-compressed
monolayers
Maximum Insertion Pressure (MIP) measurements using lipid monolayers com-
pressed to a defined target pressure 𝜋i are an easy method to assess if a peptide
is able to penetrate into the membrane. The peptide is injected underneath the
pre-compressed monolayer keeping the surface area constant. An interaction of
the peptide with the lipids leads to a change in the surface pressure𝜋. The change
of the surface pressure 𝛥𝜋 = 𝜋 − 𝜋i is plotted as a function of the initial pressure
𝜋i. A linear fitting and extrapolating to 𝛥𝜋 = 0 gives the MIP up to which the pen-
etration of the peptide into the lipid monolayer is energetically favorable [60, 61].
If this value is higher or in the range of the lateral pressure in a bilayer, found to
be between 30 and 35mN/m [62, 63], then the peptide can insert into a biological
membrane. The slope of the linear fit provides further information on the way the
peptide interacts with the lipid layer. Two scenarios are possible [64, 65]. Either
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𝛥𝜋 is independent of 𝜋i indicating that the peptide penetrates into the layer at
each initial surface pressure 𝜋i. In this case, the equilibrium surface pressure 𝜋eq
of the mixed lipid/peptide system increases with increasing 𝜋i. A stationary 𝜋eq
leads to a reduced increase in 𝛥𝜋 with increasing 𝜋i, meaning that it is more dif-
ficult for the peptide to penetrate into a compressed monolayer.
The change in surface pressure after the injection of LL-32 and LL-20 has been
monitored, and the corresponding 𝛥𝜋 versus 𝜋i curves for DPPG, DPPC, POPG
and DOPC monolayers are shown in Figures 5 and 6. A slope different from −1 in-
dicates that the equilibriumpressure is not stationary but depends on the starting
pressure 𝜋i.
In the experiments with LL-32 and the fluidmonolayers of DOPC andPOPG, ir-
regularities can be seen in the adsorption kinetics. Film instabilities might be the
Figure 5:MIP experiments with LL-20 (󳵳) and LL-32 (∙) into negatively charged POPG (left) and
DPPG (right) monolayers. Extrapolating the linear fit of 𝛥𝜋 = 𝜋 − 𝜋i versus 𝜋i to 𝛥𝜋 = 0 gives the
MIP. 5 mM HEPES, 100mMNaCl, pH 7.4, 20 ∘C, 0.2 μM peptide in solution.
Figure 6:MIP experiments with LL-20 (󳵳) and LL-32 (∙) into zwitterionic DOPC (left) and DPPC
(right) monolayers. Extrapolating the linear fit of 𝛥𝜋 = 𝜋 − 𝜋i versus 𝜋i to 𝛥𝜋 = 0 gives the MIP.
5 mM HEPES, 100mMNaCl, pH 7.4, 20 ∘C, 0.2 μM peptide in solution.
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Table 1:Maximum Insertion Pressure (MIP), and slope of the linear fit.
peptide phospholipid MIP [mN/m] slope








reason [66, 67]. LL-32 is strongly attracted by the fluid lipid monolayers and ac-
cumulates quickly at the interface. This leads to local destabilization of the lipid
monolayer which results in the drop of the surface pressure. Due to further ad-
sorption of peptides, the surface pressure increases again leading to additional
defects until the adsorption equilibrium of the peptide is reached.
The MIP and slope values are listed in Table 1. LL-32 has ahigh affinity for
negatively charged lipidmonolayers. The injection of LL-32 under pre-compressed
POPGandDPPGmonolayers leads to a strong increase in the surfacepressure. The
equilibriumpressure𝜋eq is a stationary surface pressure and themonolayer phase
has no strong influence on𝛥𝜋 and theMIP [65]. TheMIP of LL-32 is (45±3)mN/m
for DPPG and (40 ± 2) mN/m for POPG.
The injection of LL-20 underneath aDPPG monolayer leads to a constant in-
crease of 𝛥𝜋 = 10mN/m for all 𝜋i, which yields an infinite MIP reflecting only
electrostatic attraction and no hydrophobic interactions, because of the indepen-
dence from the lipid packing density (phase state). The peptide is attracted to the
charged head groups but exhibits no further interaction with the lipids. The pep-
tide could be inactivated by hindering electrostatic interactions. The effect of LL-
20 on POPGmonolayers is comparable with that of LL-32. The MIP is 38mN/m.
The MIP of LL-20 into DPPC monolayers is (32 ± 3)mN/m. Together with
the small slope of −0.5, it is obvious that LL-20 has only a low affinity for
DPPC. The same holds for DOPC monolayers. Obviously, LL-20 cannot penetrate
into zwitterionic lipid monolayers at physiologically relevant surface pressures
(30–35mN/m), independent of the lipid phase. LL-32 has a slightly higher MIP
of (35 2)mN/m into DPPC with a slope of −0.7, indicating an interaction with the
zwitterionic DPPC at low lateral pressures. The MIP of LL-32 into DOPC monolay-
ers is much higher and even comparable with that of POPG and is in agreement
with the non-pronounced cell selectivity of this peptide [24].
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IRRAS measurements at the air/water interface have been performed addi-
tionally to the MIP experiments using the more active peptide LL-32. They are ex-
tremely useful to examine if the interaction of the peptides with the lipids leads to
changes in the peptide secondary structure and the phase of the lipids. The CH
2
stretching vibrational band positions reflect the order in the hydrophobic chain
region. The amide bands are connected with the secondary structure of the pep-
tide. The OH-band intensity is related to the film thickness [52] and is therefore
influenced by the lipid tilt angle in condensed phases and the formation of ad-
sorption layers.
The spectra of the condensed DPPG film (Figure 7) show a small increase in
the 𝜈(OH) band intensity on increasing the lateral pressure. This increase in the
lipidmonolayer thickness is directly connected with the reduction of the tilt angle
determined by GIXD experiments [68].
Above 8mN/m, DPPG is in a condensed state with an all-trans conforma-
tion of the alkyl chains. The phase of the lipids can be deduced from the band
position of the symmetric and asymmetric CH
2
stretching vibrations. Values of
2919 cm
−1 for the 𝜈as(CH2) and 2849 cm
−1 for the 𝜈s(CH2) have been observed
both before and after peptide injection showing that the state of the lipids is not
affected by the peptide. This is in contrast to the experimentswith un-compressed
DPPG monolayers. There peptide injection leads to a drastic increase of the OH-
bandwhich could be caused by an increase of the lipid packingdensity connected
with a decrease of the tilt angle and the formation of an additional peptide ad-
sorption layer underneath the lipid head groups. At the same time, amide bands
(amide A∼3300 cm−1, amide I ∼1658 cm−1) appear. The amide I band position at
Figure 7: IRRA spectra of DPPG (left) and DPPG/LL-32 mixed films (right). The peptide was
injected under a pre-compressedmonolayer with 𝜋
𝑖
of 10 mN/m (dotted), 20mN/m (solid) or
30 mN/m (dotted-dashed). The spectra were measured after reaching the equilibrium pressure:
p-polarized light, 40∘ incidence angle, 5 mM HEPES, 100 mMNaCl, pH 7.4, 20 ∘C, 0.2 μM peptide
in solution.
Brought to you by | MPI fuer Kolloid- und Grenzflaechenforschung
Authenticated
Download Date | 10/8/15 4:02 PM
Peptide-Lipid Interactions in Monolayers | 1153
Figure 8: IRRA spectra of DPPC (left) and DPPC/LL-32 mixed films (right). The peptide was
injected under a pre-compressedmonolayer with 𝜋
𝑖
of 10 mN/m (dotted), 20 mN/m (solid), or
30 mN/m (dotted-dashed). The spectra were measured after reaching the equilibrium pressure:
p-polarized light, 40∘ incidence angle, 5 mM HEPES, 100mMNaCl, pH 7.4, 20 ∘C, 0.2 μM peptide
in solution.
∼1658 cm
−1 denotes the presence of the peptide with most probably an 𝛼-helical
structure.
In the case of POPG, the alkyl chains are in a disordered fluid state at 20 ∘C
leading to 𝜈s(CH2)=2855 cm
−1 and𝜈as(CH2)=2923 cm
−1. The intensity of these
bands is quite low because of the low lipid density in the LE phase and the not
well oriented transition dipole moments [69]. The presence of amide bands il-
lustrates the presence of the peptide in or close to the lipid film. The intensity
of the 𝜈(OH) of POPG is almost unchanged after peptide injection, indicating
a complete incorporation of the peptide into the lipid film and no formation of
an additional adsorption layer underneath the lipid head groups as observed for
DPPG.
In DPPC/L-32 mixed films (Figure 8), no amide bands were detected for 𝜋i >
10mN/m. For 𝜋i = 10mN/m only a small dip in the spectrum at 1658 cm
−1 can
be seen. Apart from that, the increase in the surface pressure after the peptide
injection (𝜋eq > 𝜋i) denotes a certain interaction of the peptide with the lipid in-
terface. The question arises why this peptide cannot be seen in IRRAS experi-
ments. An explanation for this could be that the peptide binds preferentially to the
air/water interface without specific interactions with the DPPC molecules. This
assumption is supported by the fact that the equilibrium pressure of the peptide
at the bare air/buffer interface is very similar to that at the air/lipid interface. The
mixed system is then phase-separated and peptide patches could be located out-
side the IR spot.
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Figure 9: CD spectra of LL-32 and LL-20 in water at 20 ∘C in the presence of POPC vesicles (solid
line for LL-32 and dotted line for LL-20) and in the presence of POPG vesicles (dashed lines,
LL-20 has the higher intensity around 195 nm). Peptide:lipid= 1 : 16.
3.3 Comparison to measurements in bulk
CD experiments have been performed with the peptides and lipid vesicles (Fig-
ure 9). Due to the high absorbance ofNaCl andHEPES in CD spectroscopy, the ex-
perimentswere performed in ultrapurewater [70]. Both peptides are unstructured
in water. The helical content was calculated to be <1% for both peptides, also for
aNaCl concentration of 100mM. The addition of POPC vesicles to the peptide
solution has only little effect on the peptide conformation. The CD spectra corre-
spond still to an unstructured peptide [70, 71], although the intensity at 230 nm
is slightly increased. However, the addition of POPG vesicles leads to adrastic
change in the peptide conformation of both LL-32 and LL-20. A positive band at
193 nm and two negative bands at 207 and 222 nm emerge. These bands are indi-
cators for an 𝛼-helix [70–72]. A formation of transmembrane pores in equilibrium
can be excluded, since transmembrane pores lead to a red-shift of the positive
band in the range of 195–200 nm and ahigher intensity of the band at 222 nm
compared to that at 208 nm [72, 73].
4 Discussion
The peptides used are fragments of the human antimicrobial LL-37 and show con-
trary behavior in biological experiments. While LL-32 is more active compared to
the mother peptide, LL-20 is active only at very high concentrations [74]. Lipid
monolayers composed of DPPG, POPG, DPPC and DOPC were used to clarify how
the lipid charge and the lipid phase influence the lipid/peptide interactions. Sur-
face sensitive IRRAS was coupled to Langmuir film balance measurements to ob-
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tain details on amolecular level. The results can be compared with CD experi-
ments with vesicles composed of POPC and POPG, respectively.
Both peptides are surface active. This surface activity is enhanced by the pres-
ence of lipids. The equilibrium surface pressure for LL-32 at a lipid covered surface
is quite high (35mN/m with DPPG and 25mN/m with DPPC). LL-20 is less sur-
face active and exhibits smaller equilibrium surface pressures in the presence of
lipids (22mN/m with DPPG and 8.5 mN/m with DPPC).
Maximum Insertion Pressure (MIP) measurements revealed the critical sur-
face pressure, up to which the peptides penetrate into lipid monolayers. For
a successful interaction with a cell membrane, the MIP should be higher than
30–35mN/m (internal lateral pressure in amembrane [62, 63]). The low MIPs of
LL-20 into DOPC and DPPC monolayers indicate that the peptide will not spon-
taneously insert into zwitterionic regions of cell membranes. The interaction of
LL-20 with negatively charged lipid monolayers is dependent on the lipid phase.
Injection of LL-20 under pre-compressed DPPG monolayers led to a constant in-
crease in the surface pressure, independent of the initial surface pressure 𝜋i. The
higher charge density of a condensed DPPG layer compared to the lower charge
density of a fluid POPG layer leads to strong electrostatic attraction, but the higher
molecular density prevents the penetration of LL-20 into the tightly packed hy-
drophobic layer region. LL-32 shows a strong affinity for both zwitterionic andneg-
atively charged lipid monolayers and an interaction at physiologically relevant
surface pressures of 30–35mN/m. LL-32 completely penetrates the fluid POPG
monolayers for𝜋 <MIP, but forms an additional adsorption layer underneath the
DPPGmonolayers.
The differences in the surface activity and MIPs for different lipids are in-
dicative for a different way of action of the peptides [51] and the selectivity of the
peptide towards different membrane compositions. Both peptides have no influ-
ence on DPPC monolayers. The CH
2
band positions of the mixed DPPC/peptide
films are the same as for DPPC at the bare air/buffer interface. The peptides most
probably adsorb in clusters and lead to a phase-separated system. Compression
of the mixed films leads to a complete squeezing-out of LL-20, but not of LL-32 (the
amide I band is still present).
For DPPG monolayers, the CH
2
band position in the IRRA spectra is indica-
tive for an expanded lipid phase proving the fluidization of the lipid film. During
the adsorption process, the peptide occupies space at the surface, compresses the
DPPGmolecules and triggers the LE/LC phase transition. The highly charged con-
densed lipid domains serve as a target for further peptide-lipid interaction. While
the peptide completely incorporates into pre-compressed POPG films, the pep-
tide injectionunderDPPGmonolayers leads to additional binding underneath the
head groups. The peptide is electrostatically bound to the head groups, but pos-
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sibly with an irregular conformation. Both peptides adopt𝛼-helical conformation
with a comparable orientation, as concluded from the amide I band position and
the corresponding dichroic ratio.
Both peptides are unstructured in solution, but adopt helical conformation
when bound to POPG vesicles. POPC vesicles have no effect on the secondary
structure of LL-20 and LL-32 in water, indicated by almost unchanged CD spec-
tra. To estimate, if the unstructured peptides can bind to POPC vesicles, some
simple calculations can be performed with the help of Mpex [75] by using the
White-Wimley scale [76]. This allows evaluating if the adsorption of the unstruc-
tured peptides to a hydrophilic-hydrophobic interface is energetically favorable.
The Gibbs energy 𝛥Gwif for the transition of the unstructured peptides from wa-
ter to a POPC interface amounts to 6.86 kcal/mol for LL-20 and 9.28 kcal/mol for
LL-32, indicating that binding of the unstructured peptide to POPC is energetically
unfavorable.𝛥G can be reduced by the formation of hydrogen bonds with the for-
mation of 𝛼-helices, which reduces 𝛥G to −0.4 kcal/mol per residue [77]. There-
fore, a helical content of ≥73% for LL-32 and ≥86% for LL-20 would be needed for
a favorable interaction.
5 Conclusions
LL-32 and LL-20 are two fragments of the human antimicrobial LL-37. They show
a contrary behavior in biological experiments. To obtain information about the
secondary structure of the peptides in bulk and confined to the air/liquid inter-
face, CD and IRRAS experiments have been performed, respectively Lipid mono-
layers (2D system) and lipid vesicles (3D system) were used as simple models for
the outer leaflet of a cell membrane.
LL-32 is more surface active and can better intercalate into lipid monolayers
compared to LL-20. Even though LL-32 has no cell-selectivity, our results show
that the peptide interacts differently with zwitterionic compared to anionicmodel
membranes. The interaction with DPPC monolayers is based on the simple inter-
calation of the peptides between the lipidmolecules, which leads to aphase tran-
sition of the lipids to a condensed phase. The interaction of LL-32with zwitterionic
lipids is in line with the observed haemolytic properties [74]. The observation that
LL-32 is able to fluidize negatively charged DPPG monolayers is extremely impor-
tant. However, this is only observed for un-compressed DPPG layers. The pene-
trated peptides compress the film and induce the LE/LC phase transition allowing
more peptide to adsorb at the interface. The larger amount of peptide leads to the
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re-appearance of the LE phase. At the moment, the question why LL-32 does not
fluidize pre-compressed condensed DPPGmonolayers remains unanswered.
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